GSK Wins False Patent Marking Suit Over Citrucel
GlaxoSmithKline PLC on Wednesday prevailed in a suit alleging it falsely marked the laxative Citrucel with expired patents, with a New York federal judge ruling following a bench trial that there...To view the full article, register now.
Already a subscriber? Click here to view full article